{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:57:06Z","timestamp":1761807426118},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2587,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1111\/j.1365-2133.2008.08686.x","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T07:51:08Z","timestamp":1213861868000},"page":"453-456","source":"Crossref","is-referenced-by-count":63,"title":["Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study"],"prefix":"10.1093","volume":"159","author":[{"given":"D.","family":"Rigopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gregoriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stratigos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Larios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Korfitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ioannides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1529-8019.2002.01521.x","article-title":"Diagnosis and management of nail psoriasis","volume":"15","author":"de Berker","year":"2002","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB2","first-page":"1452","article-title":"Therapies for psoriatic nail disease: a systematic review","volume":"31","author":"Cassel","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2133.2007.07945.x","article-title":"Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function","volume":"157","author":"Bedini","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/S0190-9622(03)00910-1","article-title":"Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis","volume":"49","author":"Rich","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(99)70047-2","article-title":"The impact of onychomycosis on quality of life: development of an international onychomycosis specific questionnaire to measure patient quality of life","volume":"41","author":"Drake","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","article-title":"Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid","volume":"139","author":"Tosti","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00015550252948220","article-title":"Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream","volume":"82","author":"Rigopoulos","year":"2002","journal-title":"Acta Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000068469","article-title":"Treatment of psoriatic nails with topical cyclosporin: a prospective randomized placebo-controlled study","volume":"206","author":"Cannavo","year":"2003","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB9","first-page":"355","article-title":"Tazarotene 0.1 gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study","volume":"68","author":"Scher","year":"2001","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1046\/j.1365-2133.2003.05392.x","article-title":"Tazarotene 0.1 gel for psoriasis of the fingernails and toenails: an open prospective study","volume":"149","author":"Bianchi","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2340\/00015555-0195","article-title":"Treatment of psoriatic nails with tazarotene cream 0.1 vs. clobetasol propionate 0.05 cream: a double-blind study","volume":"87","author":"Rigopoulos","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2004.09.012","article-title":"Remission and time of resolution of nail psoriasis during infliximab therapy","volume":"52","author":"Bianchi","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"EXPRESS study investigators. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000246274","article-title":"Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients","volume":"193","author":"de Jong","year":"1996","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1529-8019.2007.00112.x","article-title":"Biological therapy and nail psoriasis","volume":"20","author":"Lawry","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB16","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1468-3083.2006.01783.x","article-title":"Therapeutic effects of a 12-week course of alefacept on nail psoriasis","volume":"20","author":"Korver","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB17","first-page":"339","article-title":"Alefacept in the treatment of psoriatic nail disease: a proof of concept study","volume":"5","author":"Parrish","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08686.x-BIB18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jaad.2005.01.101","article-title":"Alefacept in the treatment of psoriatic nail disease: a small case series","volume":"52","author":"Cassetty","year":"2005","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.08686.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.08686.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:41:37Z","timestamp":1676382097000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/159\/2\/453\/6641241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08686.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}